REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
7.01
-0.83 (-10.54%)
Mar 31, 2025, 1:37 PM EDT - Market open

REGENXBIO Market Cap

REGENXBIO has a market cap or net worth of $350.85 million as of March 31, 2025. Its market cap has decreased by -64.85% in one year.

Market Cap
350.85M
Enterprise Value
240.95M
1-Year Change
-64.85%
Ranking
Category
Stock Price
$7.01

Market Cap Chart

Since September 17, 2015, REGENXBIO's market cap has decreased from $749.30M to $350.85M, a decrease of -53.18%. That is a compound annual growth rate of -7.65%.

History

DateMarket Cap% Change
Mar 28, 2025392.20M2.40%
Dec 31, 2024383.00M-51.50%
Dec 29, 2023789.70M-19.57%
Dec 30, 2022981.90M-29.79%
Dec 31, 20211.40B-17.57%
Dec 31, 20201.70B12.32%
Dec 31, 20191.51B0.48%
Dec 31, 20181.50B45.18%
Dec 29, 20171.04B110.87%
Dec 30, 2016491.10M12.43%
Dec 31, 2015436.80M-41.71%
View and export this data all the way back to 2015. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 738.61B
UnitedHealth Group 472.03B
Johnson & Johnson 394.52B
AbbVie 363.15B
Novo Nordisk 305.46B
AstraZeneca 229.16B
Abbott Laboratories 226.88B
Merck & Co. 225.40B
Market Cap Rankings